Put Rugiet Daily Boost in its own comparison column. It describes daily tadalafil plus DHEA in a cinnamon chew, rather than every treatment sold by Rugiet. A useful comparison keeps the medicine, the supply and the payment interval together. Otherwise a cheaper-looking figure may describe a different formula or a larger commitment.
The exact strengths, supplied quantity and full recurring bill were not verified in our November 8 check. A Ready promotion elsewhere on the provider’s site is not a Boost quote.
Availability: Public product listing; individual eligibility and current prescription require confirmation.
The exact product
The first comparison field is the actual preparation. The material distinction here is a hormone-precursor ingredient alongside tadalafil. Match every active ingredient and dosage form before looking at timing or unit cost. Products with similar names can contain different drugs; products with the same drug can use different formulations. Neither resemblance establishes interchangeability. The identity table is a record of the provider's listing, not a prescription-selection tool.
| Provider | Rugiet |
|---|---|
| Listed active ingredients | Tadalafil + DHEA |
| Dosage form | Compounded daily cinnamon chew |
| Regulatory distinction | Compounded preparation; the finished product is not FDA-approved. |
| Source basis | Rugiet: Daily Boost product information |
Price, supply and payment
We could not verify the complete price of a Daily Boost plan. Treat the details below as the boundaries of that quote. Only calculate a unit figure when both the charge and the supplied quantity belong to the same offer; only calculate a monthly equivalent when the payment term is known. A blank quantity or renewal price should remain blank. Comparing invented complete totals is less reliable than explaining why two published offers cannot yet be matched.
| Selected strengths | Not verified |
|---|---|
| Quantity supplied | Not verified |
| Initial and renewal charge | Complete product-specific quote not verified |
| Separate promotion | Do not transfer a Ready offer to this product |
What the research can support
Evidence is another comparison field, not a bonus point for a more complicated formula. This product's relevant evidence includes a small favorable 1999 DHEA trial and a later trial without significant sexual-function benefit. The missing comparison concerns applicability of those studies to the exact Boost preparation. A valid superiority claim would need a suitable comparator and outcome, not merely different marketing language. Record whether the source measured erection outcomes, subjective preference, absorption or something else before treating a percentage or timing claim as comparable.
The earlier abstract describes selected men with low DHEA sulfate and warns that the sample was too small for relevant statistical analysis. The later report found no significant difference across four sexual-function instruments. Neither study tested this chew. Earlier study · Later study
| Evidence boundary | a small favorable 1999 DHEA trial and a later trial without significant sexual-function benefit |
|---|---|
| Not established here | applicability of those studies to the exact Boost preparation |
| Clinical and regulatory references | Reiter et al. (1999): DHEA and erectile dysfunction · Morales et al. (2009): androgens and sexual function · MedlinePlus: Tadalafil · FDA: Compounding and the FDA — questions and answers · DailyMed: Tadalafil prescribing information, including section 5.11 · MedlinePlus: Sildenafil |
| Earlier trial | 40 selected men; six months; not a Boost study |
| Later trial | 86 randomized; 79 completed; no significant sexual-function differences |
Safety questions for the prescriber
Cost matching does not establish clinical suitability. A clinician must review nitrates, recreational nitrites, riociguat, other ED drugs, blood-pressure treatment and relevant medical history before prescribing. Do not try to recreate Rugiet Daily Boost with cheaper separate medicines. A do-it-yourself combination can create a new exposure without reproducing the studied or prescribed preparation. The specific safety distinction below can change which comparisons are meaningful for an individual.
The product safety page mixes in another product name and an ingredient-approval statement we have not independently confirmed. Those statements cannot establish the finished preparation’s safety. The current tablet labels address their named products. Label context
| DHEA | A hormone precursor; different studies do not establish the exact combination’s benefits or suitability. |
|---|
Availability and the actual prescription
There is little value in ranking a price for an offer you cannot select. Our access finding is: Public product listing; individual eligibility and current prescription require confirmation. Account restrictions and a medical eligibility decision are different filters. Obtain confirmation of the exact current product before comparing cancellation rules or moving away from an existing plan. A product page that remains reachable is evidence of public documentation, not a guarantee of inventory or enrollment.
Refills, changes and cancellation
Add a change-of-treatment row to the budget. Ask whether a new formula requires another assessment, a replacement supply or a separate charge, and whether the current order can still be stopped. For the clinical side, use “What finding supports DHEA in my case, and how will its effects be assessed?” The two answers should come from the appropriate teams. A support agent's billing explanation does not settle medication safety, and a clinical message does not necessarily stop automatic processing.
Keep the next billing date and the pharmacy’s processing status in the same written request. A notice period tied to one event is not automatically a deadline for another. Ask the service to identify the rule for the selected order before relying on it.
| Membership | 30- and 90-day membership terms; confirm fees and the complete product invoice. |
|---|---|
| Cancellation terms | Terms specify 72 hours before billing and 48 hours before monthly processing; support mentions 24 hours before processing. |
| Timing distinction | Different deadlines refer to different events; confirm the rule for the selected order. |
| Refund boundary | Processing prevents cancellation; ordinary lack of efficacy, side effects or flavor are not refund grounds. |
| Policy sources | Rugiet: terms and conditions · Rugiet Support: canceling an order or subscription · Rugiet Support: treatment response and refunds · Rugiet Support: membership options and inclusions |
Compare named products
The alternatives below are selected because they share an ingredient, format or clinical question. They are not ranked by efficacy. Compare them using the same columns: complete ingredients, supplied form, prescribed schedule, quantity, amount due and renewal. If one column remains unknown, identify that limitation in the comparison rather than awarding the offer a value advantage based on a starting banner.
Questions to keep with the offer
The decision-ready comparison is a written quote plus a prescribing explanation. The public records for Rugiet Daily Boost can narrow the questions but cannot provide those personal answers. No test purchase, clinical trial or pharmacy inspection was performed for this review. Sources identify advertised facts and evidence limits; commercial presentation elsewhere on this publication is not a clinical score.
| Ask about this formula | What finding supports DHEA in my case, and how will its effects be assessed? |
|---|---|
| Ask about the payment | What are the exact quantity, total due now, renewal amount and notice deadline? |
| Ask about a change | Who confirms the medical instructions, pharmacy order and next account charge? |
When to get urgent help
An erection lasting more than four hours or chest pain requires emergency care. Tell the treating clinician what was taken and when.
Sudden hearing or vision loss needs prompt medical attention. Do not wait for an ordinary account-support reply.
Back to all individual product reviews
Check the source
Each entry dates the source record used for this file. An access attempt does not refresh an unavailable offer. Provider material establishes advertised terms, not independently verified clinical results.
- Rugiet: Daily Boost product informationProvider product page; tadalafil and DHEA combination · Checked 2026-11-08
- Reiter et al. (1999): DHEA and erectile dysfunctionPrimary placebo-controlled study, 40 selected men; indexed abstract reviewed · Checked 2026-11-08
- Morales et al. (2009): androgens and sexual functionPrimary randomized study, 86 men; indexed abstract reviewed; no significant sexual-function benefit · Checked 2026-11-08
- Rugiet: terms and conditionsProvider terms; billing and processing deadlines differ · Checked 2026-11-08
- Rugiet Support: canceling an order or subscriptionProvider support; member portal steps and processing restrictions · Checked 2026-11-08
- Rugiet Support: treatment response and refundsProvider policy; refund exclusions and 24-hour order-change notice · Checked 2026-11-08
- Rugiet Support: membership options and inclusionsProvider support; plan intervals, shipping, and consultation fees · Checked 2026-11-08
- MedlinePlus: TadalafilDrug information; standard tadalafil products · Checked 2026-10-07
- FDA: Compounding and the FDA — questions and answersGovernment guidance on compounded medications · Checked 2026-10-07
- DailyMed: Tadalafil prescribing information, including section 5.11Prescribing label; not evidence for the 4Play combination · Checked 2026-10-07
- MedlinePlus: SildenafilDrug information; standard sildenafil products · Checked 2026-10-07
- Product safety page Provider text; template inconsistencies require caution · Checked 2026-11-08
- Tadalafil tablet label Individual tablet labeling · Checked 2026-11-08